You are viewing the site in preview mode
Skip to main content
|
Company (Country)
|
Vaccine
|
Partnership
|
Stage of development
|
|---|
|
Vabiotech (Vietnam)
|
mORCVAX
|
IVI re-formulated redeveloped the process to meet WHO standards
|
Licensed in Vietnam
|
|
Shanat (India)
|
Shancol
|
Technology transfer May 2008
|
Licensed in India (Feb 2009)
|
|
WHO prequalified Sep 2011
|
|
Eubiologics (Korea)
|
Euvichol
|
Technology transfer May 2010–2011
|
Korean export license 2014
|
|
WHO prequalified Dec 2015
|
|
Incepta (Bangladesh)
|
Cholvax
|
Technology transfer May 2014
|
IVI conducting clinical trial in Bangladesh, license expected in 2017–2018
|
